Eisai have published a series of Oxime and Oxime Ether 12,14-Dichlorodehydroabietic Acid derivative BK Channel-Opening Agents
Filed under: Uncategorized | Tagged: BK, channel, Eisai, preclinical, Research | Leave a Comment »
NeurogesX Submit NDA for NGX-4010 for Treatment of Postherpetic Neuralgia (PHN)
Posted on October 24, 2008 by crimsoncanary
NeurogesX have submitted a new drug application (NDA) with the U.S. FDAS for NGX-4010 Dermal Capsaicin Patch for the management of pain due to postherpetic neuralgia (PHN).
Filed under: Uncategorized | Tagged: Adenosine A2A, antagonist, Neurocrine Biosciences, preclinical, Research | Leave a Comment »
Merck publish series of T-Type Calcium Channel blockers
Posted on September 26, 2008 by crimsoncanary
Merck have published a series of T-Type Calcium Channel blockers
Filed under: Uncategorized | Tagged: ca channel, Calcium Channel, Merck, preclinical, Research | Leave a Comment »
Cellectricon to incorporate Tecella’s Richmond patch clamp amplifier in next generation Dynaflow HT platform
Posted on June 24, 2008 by crimsoncanary
Cellectricon have announced that they will be incorporating Tecella’s Richmond patch clamp amplifier in next generation Dynaflow HT platform
Filed under: Uncategorized | Tagged: Cellectricon, Licensing, preclinical, Research, Tecella | Leave a Comment »
